DFCI Patent Rights Clause Samples
The DFCI Patent Rights clause defines the ownership, management, and use of patents developed or held by the Dana-Farber Cancer Institute (DFCI) in the context of a contract or agreement. This clause typically outlines which party retains rights to inventions, how intellectual property arising from joint research is handled, and the procedures for licensing or commercializing such patents. For example, it may specify that DFCI retains ownership of any patents it develops, while granting the other party certain rights to use or license the technology. The core function of this clause is to clearly allocate intellectual property rights and responsibilities, thereby preventing disputes and ensuring that both parties understand their rights regarding patented inventions.
DFCI Patent Rights. Subject to the terms and conditions set forth in this Agreement, DFCI hereby grants to Licensee an exclusive (except as set forth in Section 4.1.4 below), worldwide, royalty-bearing license under the DFCI Patent Rights and [**] Patent Rights solely to develop, make, have made, use, market, offer for sale, sell and import Licensed Products in the Field.
DFCI Patent Rights. The term “DFCI Patent Rights” shall mean all Patent Rights that C4T Controls pursuant to the Exclusive License Agreement by and between DFCI and C4T dated December 16, 2015, amended on May 11, 2016, and as may be further amended from time to time.